Background: A central aim for pediatric nutrition is to develop infant formula compositionally closer to human milk. Milk fat globule membranes (MFGM) have shown to have functional components that are found in human milk, suggesting that addition of bovine sources of MFGM (bMFGM) to infant formula may promote beneficial outcomes potentially helping to narrow the gap between infants who receive human breast milk or infant formula. The objective of the current study is to determine how the addition of bMFGM in infant formula and consumption in early infancy affects physical growth and brain development when compared to infants fed with a standard formula and a reference group of infants fed with mother's own milk.
Methods: Single center, double-blind, and parallel randomized controlled trial. Planned participant enrollment includes: infants exclusively receiving breast milk (n = 200; human milk reference group; HM) and infants whose mothers chose to initiate exclusive infant formula feeding before 4 months of age (n = 340). The latter were randomized to receive one of two study formulas until 12 months of age: 1) cow's milk based infant formula that had docosahexaenoic (DHA) (17 mg/100 kcal) and arachidonic acid (ARA) (25 mg/100 kcal); 1.9 g protein/100 kcal; 1.2 mg Fe/100 kcal (Standard formula; SF) or 2) a similar infant formula with an added source of bovine MFGM (whey protein-lipid concentrate (Experimental formula; EF). Primary outcomes will be: 1) Physical growth (Body weight, length, and head circumference) at 730 days of age; and 2) Cognitive development (Auditory Event-Related Potential) at 730 days of age. Data will be analyzed for all participants allocated to each study feeding group.
Discussion: The results of this study will complement the knowledge regarding addition of bMFGM in infant formula including support of healthy growth and improvement of neurodevelopmental outcomes.
Trial Registration: NCT02626143, registered on December 10th 2015.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236373 | PMC |
| http://dx.doi.org/10.1186/s12887-020-02087-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Barriers and drivers to exclusive breastfeeding in Kyrgyzstan: a qualitative study with mothers and health workers.
Int Breastfeed J
January 2025
Behavioural and Cultural Insights Unit, WHO Regional Office for Europe, Copenhagen, Denmark.
Background: The WHO/UNICEF global nutrition target for exclusive breastfeeding for six months is at least 70% of infants by 2030. However, global prevalence rates are 48% with variations between countries and within regions. Kyrgyzstan has consistently high early breastfeeding initiation rates, yet exclusive breastfeeding for six months is 46%.
View Article and Find Full Text PDFMetabolic engineering of Escherichia coli BL21(DE3) cocultured with glucose and xylose for efficient production of 2'-fucosyllactose.
Bioresour Technol
January 2025
State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu 214122, China.
2'-Fucosyllactose (2'-FL) is the most abundant human milk oligosaccharide (HMO) and has been approved to be commercially added to infant formula. Microbial synthesis from exogenous lactose via metabolic engineering is currently the major approach to production of 2'-FL. Replacement of lactose with cheaper sugars such as glucose and sucrose has been studied to reduce the production costs.
View Article and Find Full Text PDFComplementary Food and Obesity.
Ann Nutr Metab
January 2025
GENUD (Growth, Exercise, Nutrition and Development) Research Group, University of Zaragoza, Instituto Agroalimentario de Aragón (IA2), and Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain.
Background: Early infant feeding is essential for children's development and future health, particularly in preventing obesity, which is the most common nutrition-related disorder in children worldwide.
Summary: Obesity, characterized by excess body fat and numerous complications, arises from a combination of genetic susceptibility and an obesogenic environment, including lifestyle behaviors related to energy balance. Eating habits start to be shaped early in life, making the introduction of solid foods a critical period.
Effects of Infant Formula Supplemented With Prebiotics on the Gut Microbiome, Gut Environment, Growth Parameters, and Safety and Tolerance: A Systematic Review and Meta-Analysis.
Nutr Rev
January 2025
Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA 70808, United States.
Context: Prebiotics are often added to infant formulas to mimic the benefits of oligosaccharides found in human milk.
Objective: This systematic review and meta-analysis evaluated the effects of prebiotic-supplemented cow's milk-based formula on the gut microbiota, gut environment, growth parameters, and safety and tolerance in infants ≤6 months old, compared with a standard formula or human milk comparator.
Data Sources: Searches were performed in the PubMed, Embase, Cochrane Central Register of Controlled Trials, and ProQuest Dissertations & Theses databases.
Comparative analysis of the structure and content of N-glycans from different commercial whey protein materials.
J Food Sci
January 2025
College of Food Science and Engineering, Tianjin University of Science & Technology, Tianjin, China.
Infant formulas are constantly being updated and upgraded, and N-glycans are functional glycans that have not been fully exploited to date. Commercial whey protein materials are often used as basic ingredients in infant formulas. Therefore, it is important to study N-glycans in commercial whey protein materials.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!